Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lovisa Sandberg"'
Publikováno v:
Caring is Sharing – Exploiting the Value in Data for Health and Innovation ISBN: 9781643683881
In pharmacovigilance, signal assessment of a medicinal product and adverse event can involve reviewing prohibitively large numbers of case reports. A prototype of a decision support tool guided by a needs assessment was developed to help manual revie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d785301c08460ed2741b341a3aa732e
https://doi.org/10.3233/shti230213
https://doi.org/10.3233/shti230213
Publikováno v:
Drug Safety
Introduction In the treatment of the individual patient, a vision is to achieve the best possible balance between benefit and harm. Such tailored therapy relies upon the identification and characterisation of risk factors for adverse drug reactions.
Autor:
Anna Pierini, Ester Garne, Vera Nelen, Anna Materna-Kiryluk, Clara Cavero-Carbonell, Maria Loane, Kari Klungsøyr, Anke Rissmann, Nathalie Lelong, Babak Khoshnood, Joan K Morris, Helen Dolk, Awi Wiesel, Amanda Nevill, Inger Öhman, Tomas Bergvall, Mary O'Mahony, Ingeborg Barišić, Reneé Lutke, David Tucker, Lyubov Yevtushok, Alana Cavadino, Miriam Gatt, Anna Latos-Bielenska, Hanitra Randrianaivo, Olatz Mokoroa, Lovisa Sandberg, Kristina Star, Marie-Claude Addor
Publikováno v:
Drug Safety, 44(7), 765-785. ADIS INT LTD
Drug Safety
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cavadino, A, Sandberg, L, Öhman, I, Bergvall, T, Star, K, Dolk, H, Loane, M, Addor, M C, Barisic, I, Cavero-Carbonell, C, Garne, E, Gatt, M, Khoshnood, B, Klungsøyr, K, Latos-Bielenska, A, Lelong, N, Lutke, R, Materna-Kiryluk, A, Nelen, V, Nevill, A, O’Mahony, M, Mokoroa, O, Pierini, A, Randrianaivo, H, Rissmann, A, Tucker, D, Wiesel, A, Yevtushok, L & Morris, J K 2021, ' Signal Detection in EUROmediCAT : Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference ', Drug Safety, vol. 44, no. 7, pp. 765-785 . https://doi.org/10.1007/s40264-021-01073-z
Drug Safety
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Cavadino, A, Sandberg, L, Öhman, I, Bergvall, T, Star, K, Dolk, H, Loane, M, Addor, M C, Barisic, I, Cavero-Carbonell, C, Garne, E, Gatt, M, Khoshnood, B, Klungsøyr, K, Latos-Bielenska, A, Lelong, N, Lutke, R, Materna-Kiryluk, A, Nelen, V, Nevill, A, O’Mahony, M, Mokoroa, O, Pierini, A, Randrianaivo, H, Rissmann, A, Tucker, D, Wiesel, A, Yevtushok, L & Morris, J K 2021, ' Signal Detection in EUROmediCAT : Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference ', Drug Safety, vol. 44, no. 7, pp. 765-785 . https://doi.org/10.1007/s40264-021-01073-z
Introduction\ud Knowledge on the safety of medication use during pregnancy is often sparse. Pregnant women are generally excluded from clinical trials, and there is a dependence on post-marketing surveillance to identify teratogenic medications.\ud \
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b86e364d11f5eb4a54c92d34d60923fb
Autor:
H. Taavola, Rebecca E. Chandler, Lovisa Sandberg, Saori Soejima, Rika Wakao, Eiko Iwasa, G. Niklas Norén
Publikováno v:
Drug Safety
Introduction Adverse event reporting patterns vary between countries, reflecting differences in reporting culture, clinical practice and underlying patient populations. Japan collects about 60,000 domestic adverse event reports yearly and shares seri
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose vigiRank is a data-driven predictive model for emerging safety signals. In addition to disproportionate reporting patterns, it also accounts for the completeness, recency, and geographic spread of individual case reporting, as well as the ava
Autor:
Pia Caduff-Janosa, Kristina Star, I. Ralph Edwards, Imti Choonara, Lovisa Sandberg, Tomas Bergvall
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose The purpose of this study is to uncover previously unrecognised risks of medicines in paediatric pharmacovigilance reports and thereby advance a safer use of medicines in paediatrics. Methods Individual case safety reports (ICSRs) with ages l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef6a6e2e36cf0b1b4ace96fa7fb4d67e
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390043
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-390043
Publikováno v:
Pharmacoepidemiology and Drug Safety
Purpose To explore whether and how longitudinal medical records could be used as a source of reference in the early phases of signal detection and analysis of novel adverse drug reactions (ADRs) in a global pharmacovigilance database. Methods Drug an